Dr. Amar Rewari Featured on Patient Power: At-Home IVIG Therapy for CLL Patients

Dr. Amar Rewari recently provided his medical expertise for a Patient Power article titled "IVIG Therapy at Home: What to Know". The piece explores the viability and benefits of at-home intravenous immunoglobulin (IVIG) therapy for patients navigating Chronic Lymphocytic Leukemia (CLL).

In the feature, Dr. Rewari explained that IVIG is utilized to strengthen the immune systems of patients who have low antibody levels and experience recurrent infections. He outlined the process for transitioning to home care, advising that patients should initially receive their infusions in a clinical setting to ensure they tolerate the treatment well. Once cleared, patients who are medically stable and have a reliable support system can safely receive their therapy at home. Dr. Rewari highlighted that this transition serves as a massive quality-of-life improvement, allowing patients to avoid the stress of travel and waiting rooms while significantly reducing their risk of exposure to other illnesses.